IMPACT OF LONG-ACTING BRONCHODILATOR THERAPY ON MORTALITY IN COPD: A REAL-LIFE RETROSPECTIVE COHORT STUDY

被引：1
|
作者：
Manoharan, A. [1 ]
Short, P. M. [1 ]
Anderson, W. J. [1 ]
Lipworth, B. J. [1 ]
机构：
[1] Univ Dundee, Dundee, Scotland
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.380
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A179 / A180
页数：3
相关论文
共 50 条
  • [31] Prevalence of COPD, Disease Severity, and Symptoms in Subjects on Long-Acting Bronchodilator Monotherapy for COPD
    Crater, G.
    Yawn, B.
    Bailey, W. C.
    Dransfield, M. T.
    Emmett, A.
    O'Dell, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [32] The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study
    Raciti, Loredana
    De Luca, Rosaria
    Raciti, Gianfranco
    Arcadi, Francesca Antonia
    Calabro, Rocco Salvatore
    MEDICAL SCIENCES, 2022, 10 (03)
  • [33] The Impact Of Tiotropium On Mortality When Added To Inhaled Corticosteroids And Long-Acting Beta Agonist Therapy In COPD
    Short, P. M.
    Anderson, W. J.
    Williamson, P. A.
    Lipworth, S. I. W.
    Elder, D. H. J.
    Schembri, S.
    Lipworth, B. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [34] The Impact of Tiotropium on Mortality and Exacerbations When Added to Inhaled Corticosteroids and Long-Acting β-Agonist Therapy in COPD
    Short, Philip M.
    Williamson, Peter A.
    Elder, Douglas K. J.
    Lipworth, Samuel I. W.
    Schembri, Stuart
    Lipworth, Brian J.
    CHEST, 2012, 141 (01) : 81 - 86
  • [35] Bronchodilator Response To The Long-Acting Bronchodilator Combination Of Umeclidinium/vilanterol Across Subgroups Of Patients With COPD
    Han, M. K.
    Kalberg, C.
    Brooks, J.
    Church, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] Comparative Effectiveness Of Tiotropium Compared To No Long-Acting Bronchodilator After A Hospitalization For COPD
    Roberts, M. H.
    Mapel, D. W.
    Petersen, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [37] Retrospective study on the use of LABA/LAMA therapy (long acting bronchodilator agent/long acting muscarinic agent) in patients with severe COPD at first diagnosis
    Bini, Francesco
    Grassi, Noemi
    De Lauretis, Angelo
    Bodini, Bruno
    Arosio, Cristina
    Vaghi, Adriano
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [38] Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized TreatmentOf COPD
    Donohue, James F.
    Mahler, Donald A.
    Sethi, Sanjay
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2947 - 2958
  • [39] Which long-acting bronchodilator is most cost-effective for the treatment of COPD?
    Hoogendoorn, M.
    Kappelhoff, B. S.
    Overbeek, J. A.
    Wouters, E. F. M.
    Rutten-van Molken, M. P. M. H.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (08): : 357 - 364
  • [40] Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)
    Grimaldi-Bensouda, Lamiae
    Rouillon, Frederic
    Astruc, Bernard
    Rossignol, Michel
    Benichou, Jacques
    Falissard, Bruno
    Limosin, Frederic
    Beaufils, Beatrice
    Vaiva, Guillaume
    Verdoux, Helene
    Moride, Yola
    Fabre, Alban
    Thibaut, Florence
    Abenhaim, Lucien
    SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 187 - 194
12345